Screener
Vor Biopharma VOR Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Vor Biopharma’s reported figures.
The source filing: Vor Biopharma’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 8:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220689
FAQ
- What is Vor Biopharma's invested capital?
- Vor Biopharma (VOR) reported invested capital of -$317.36M in Q1 2026.
- How has Vor Biopharma's invested capital changed year-over-year?
- Vor Biopharma's invested capital decreased by 778.1% year-over-year, from $46.8M to -$317.36M.
- What is the long-term trend for Vor Biopharma's invested capital?
- Over 5 years (2020 to 2025), Vor Biopharma's invested capital has grown at a 44.2% compound annual growth rate (CAGR), from -$89.31M to -$557.8M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Vor Biopharma's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude